Stocks and Investing Stocks and Investing
Wed, October 4, 2023

Michael Leithead Maintained (CC) at Hold with Decreased Target to $31 on, Oct 4th, 2023


Published on 2024-10-28 06:42:33 - WOPRAI, Michael Leithead
  Print publication without navigation


Michael Leithead of Barclays, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $40 to $31 on, Oct 4th, 2023.

Michael has made no other calls on CC in the last 4 months.



There are 5 other peers that have a rating on CC. Out of the 5 peers that are also analyzing CC, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vincent Andrews of "Morgan Stanley" Reiterated at Hold and Held Target at $33 on, Tuesday, August 1st, 2023
  • Arun Viswanathan of "RBC Capital" Maintained at Hold with Increased Target to $40 on, Monday, July 31st, 2023
  • Matthew DeYoe of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $37 on, Thursday, June 22nd, 2023


These are the ratings of the 2 analyists that currently disagree with Michael


  • John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $53 on, Wednesday, August 2nd, 2023
  • Joshua Spector of "UBS" Maintained at Strong Buy with Increased Target to $43 on, Tuesday, June 13th, 2023
Contributing Sources